Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Analytical Toxicology|January 2, 2015
Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometryDaniel Pasin, Sergei Bidny, Shanlin Fu
Drug Testing and Analysis|January 31, 2017
Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposesDaniel Pasin, Adam Cawley, Sergei Bidny, et al.
Analytical and Bioanalytical Chemistry|June 22, 2017
Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical reviewDaniel Pasin, Adam Cawley, Sergei Bidny, et al.
Journal of Analytical Toxicology|December 26, 2025
Applications of Machine Learning for the General Unknown Screening of HRMS data within Forensic ToxicologySamantha Swan, Maria Sarkisian, Daniel Pasin, et al.
Archives of Toxicology|February 10, 2022
Developments in high-resolution mass spectrometric analyses of new psychoactive substancesJoshua Klingberg, Bethany Keen, Adam Cawley, et al.
Journal of Analytical Toxicology|November 25, 2016
Simultaneous Screening and Quantification of Basic, Neutral and Acidic Drugs in Blood Using UPLC-QTOF-MSSergei Bidny, Kim Gago, Phuong Chung, et al.
Drug Testing and Analysis|July 7, 2020
Finding the proverbial needle: Non-targeted screening of synthetic opioids in equine plasmaJoshua Klingberg, Adam Cawley, Ronald Shimmon, et al.
Forensic Science International|July 9, 2024
Retrospective screening of new psychoactive substances (NPS) in post mortem samples from 2014 to 2021Per Ole M Gundersen, Daniel Pasin, Lars Slørdal, et al.
Analytica Chimica Acta|October 9, 2021
Development of a single retention time prediction model integrating multiple liquid chromatography systems: Application to new psychoactive substancesDaniel Pasin, Christian Brinch Mollerup, Brian Schou Rasmussen, et al.
Molecules (Basel, Switzerland)|June 12, 2026
Explainable Artificial Intelligence (xAI) for 5-HT2A Receptor Binding Affinity of New Psychoactive SubstancesVerena Schöning, Katharina Elisabeth Grafinger, Daniel Pasin, et al.
Pageof 2